Search results
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 6 days agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 11 hours agoThe American Society of Clinical Oncology held its annual conference in Chicago this past week,...
COVID Shot After Acute Coronary Syndrome Might Not Prevent Further Events
MedPage Today· 6 days agoCensoring the first 90 days post-vaccination in this non-randomized comparison, people with ACS who...
Docs Endorsing Products on X May Not Disclose Company Ties
Medscape· 5 hours agoNearly one in three physicians endorsing drugs and devices on the social media platform X did not...
'Outstanding' Results for Osimertinib: Stage III EGFR+ NSCLC
Medscape· 2 days agoResults from the LAURA trial will change practice once its label gets expanded, experts said at the...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 6 days agoPerformance of an Industry Player Pfizer belongs to the Zacks Large Cap Pharmaceuticals industry....
FDA panel rejects MDMA therapy for treating patients with PTSD
WSB Radio· 1 day agoAn independent advisory panel of the Food and Drug Administration on Tuesday rejected the use of...
The Most Profitable Biotechnology Company in the World
Insider Monkey via Yahoo Finance· 6 days agoIn this article, we will be taking a look at the most profitable biotechnology company in the world. If you want to learn about more, head straight to the 15 Most Profitable Biotechnology Companies ...
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC
MedPage Today· 4 days agoEGFR testing now needed for all patients with stage III disease, experts say
Is Semaglutide the
Medscape· 3 days agoThere has been much hyperbole since the presentation of results from the SELECT cardiovascular outcomes trial (CVOT) at this year's European Congress on...
